MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
35.00
-2.68 (-7.11%)
At close: Feb 11, 2026, 4:00 PM EST
35.35
+0.35 (0.99%)
After-hours: Feb 11, 2026, 6:54 PM EST
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $1.65 billion as of February 11, 2026. Its market cap has increased by 375.33% in one year.
Market Cap
1.65B
Enterprise Value
1.26B
1-Year Change
375.33%
Ranking
Category
Stock Price
$35.00
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has increased from $509.66M to $1.65B, an increase of 223.82%. That is a compound annual growth rate of 129.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 1.78B | 25.46% |
| Dec 31, 2025 | 1.42B | 129.95% |
| Dec 31, 2024 | 615.88M | 20.84% |
| Sep 13, 2024 | 509.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Stoke Therapeutics | 1.82B |
| MannKind | 1.81B |
| Vericel | 1.79B |
| RAPT Therapeutics | 1.79B |
| Ardelyx | 1.78B |
| Tango Therapeutics | 1.74B |
| Pharvaris | 1.74B |
| Corvus Pharmaceuticals | 1.73B |